Regulatory Press Releases

Revenues increased by 56 percent to 63.3 MSEK (40.6) and the organic growth amounted to 14 percent with revenues of 46.1 MSEK. Operating profit increased by 72 percent 8.9 MSEK (5.2). Compared to the same quarter last year, business unit Surgical Instruments doubled its revenue driven by the acquired volume of S&T. For the same period, business unit Surgical Tables increased sales by 25 percent...

Revenues for the first quarter increased by 72 percent to 61.6 MSEK (35.8) and the organic growth amounted to 21 percent with revenues of 43.3 MSEK. Operating profit increased to 7.5 MSEK (4.0). ”I can conclude that revenues for business unit Surgical Tables never has been higher than during the first quarter 2022. Most notable is the growth outside the US where sales increased by 52 percent...

Stille’s Annual Report for the business year of 2021 is being published today and can be found on the company website www.stille.se. The Annual Report 2021 can also be found in full as an attachment to this press release. Torshälla, March 31st, 2022. For more information, please contact: Hanna Ernestam Wilkman CEO and President +46 (0)72 402 10 88 | hanna.e.wilkman@stille.se Stille AB...

Revenues for the fourth quarter reached 59.6 MSEK (45.0), including recently acquired S&T whose sales exceeded expectations. Excluding the acquisition sales amounted to 44.0 MSEK despite challenges in the US for both business units. ”To strengthen growth in the US-market, we have in December launched a new general surgery table, GS2®, in an exclusive collaboration with GE Healthcare...

Stille delivered growth both organically as well as through the acquisition of Swiss company S&T AG. Organic sales grew by 12% compared to the same quarter previous year. “The acquisition of S&T means that business unit Surgical Instruments has doubled in size. The integration of the company is progressing according to plan. Our main focus is to realize identified cross-selling synergies...